Fundz

Amphista Therapeutics Appoints Antony Mattessich as Chief Executive Officer

PRIVATESep 03, 2024

Position

Chief Executive Officer

Company

Amphista Therapeutics

Antony Mattessich
antony.mattessich@amphista.com
CambridgeBiotechnologyHealth CareTherapeutics

Description

Amphista Therapeutics announces the appointment of Antony Mattessich as its Chief Executive Officer, contributing to the acceleration of the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein degraders into the clinic and building a robust pipeline. Antony Mattessich, an experienced CEO, brings an impressive track record progressing programs from discovery, through clinical development and commercial success, with extensive experience in CNS, haemato-oncology, immunology, and metabolics.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Amphista Therapeutics, and when

A new leader at Amphista Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Amphista Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amphista Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amphista Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amphista Therapeutics

Location

Cambridge, England, United Kingdom

About

Amphista Therapeutics is focused on transforming the lives of patients with severe diseases, including cancer and neurodegenerative disease, through the advancement of next generation targeted protein degradation (TPD) medicines. Its portfolio offers the potential for first- and/or best-in-class assets and expanding the offering of TPD medicines beyond CRBN and VHL-based agents.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amphista Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Antony
Likely contact at this company
••••••••@••••••••

See Antony's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Amphista Therapeutics's next move

Learn about Strategic plan

Amphista Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.